REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330959. A total of 4 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $744,403 | +26.3% | 64,900 | +254.6% | 0.00% | – |
| Q1 2023 | $589,443 | -82.7% | 18,300 | -90.1% | 0.00% | -100.0% |
| Q4 2022 | $3,398,486 | +16.4% | 184,100 | +70.3% | 0.00% | +100.0% |
| Q3 2022 | $2,919,000 | +145.3% | 108,100 | +25.6% | 0.00% | 0.0% |
| Q2 2022 | $1,190,000 | – | 86,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 7,400 | $110,000 | 0.00% |
| SIMPLEX TRADING, LLC | 33 | $48,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |